P2x7 mrna expression in non-small cell lung cancer: MicroRNA regulation and prognostic value

Oncology Letters

Volumn 9, Issue 1, 2015, Pages 449-453

  Boldrini, Laura ^a   Giordano, Mirella ^a   Alì, Greta ^b   Melfi, Franca ^b   Romano, Gaetano ^a   Lucchi, Marco ^b   Fontanini, Gabriella ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

MiRNA; Non small cell lung cancer; P2X7; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LET 7 G; MESSENGER RNA; MICRORNA; MICRORNA 205; MICRORNA 21; PURINERGIC P2X7 RECEPTOR; RNU6B; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; DNA ISOLATION; FEMALE; GENE CONTROL; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; K RAS GENE; LARGE CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON SMALL CELL LUNG CANCER; ONCOGENE RAS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA STABILITY; SQUAMOUS CELL CARCINOMA; SURVIVAL; TUMOR GROWTH;

EID: 84911415028     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2620     Document Type: Article

References (27)

1. Buell GN, Talabot F, Gos A, Lorenz J, Lai E, Morris MA and Antonarakis SE: Gene structure and chromosomal localization of the human P2X7 receptor. Receptors Channels 5: 347-354, 1998.
2. Sluyter R and Stokes L: Significance of P2X7 receptor variants to human health and disease. Recent Pat DNA Gene Seq 5: 41-54, 2011.
3. Li X, Qi X, Zhou L, Catera D, Rote NS, Potashkin J, Abdul-Karim FW and Gorodeski GI: Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. Gynecol Oncol 106: 233-243, 2007.
4. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW and Gorodeski GI: MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steadystate levels of the transcript. J Biol Chem 283: 28274-28286, 2008.
5. Rahman OA, Sasvari-Szekely M, Szekely A, Faludi G, Guttman A and Nemoda Z: Analysis of a polymorphic microRNA target site in the purinergic receptor P2RX7 gene. Electrophoresis 31: 1790-1795, 2010.
6. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
7. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R and Pasquinelli AE: Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122: 553-563, 2005.
8. Lim LP, Lau NC, Garrett-Engele P, et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773, 2005.
9. Lai EC: Predicting and validating microRNA targets. Genome Biol 5: 115, 2004.
10. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
11. Xie X, Lu J, Kulbokas EJ, et al: Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 434: 338-345, 2005.
12. Travis WD, Brambilla E, Muller-Hemerlink HK and Harris CC: World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press, 2004.
13. Travis WD, Brambilla E, Noguchi M, et al: International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: 244-285, 2011.
14. Capodanno A, Boldrini L, Alì G, Pelliccioni S, Mussi A and Fontanini G: Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumors. Oncol Rep 28: 1559-1566, 2012.
15. Fuller SJ, Stokes L, SkarRatt KK, Gu BJ and Wiley JS: Genetics of the P2X7 receptor and human disease. Purinergic Signal 5: 257-262, 2009.
16. Brennecke J, Stark A, Russell RB and Cohen SM: Principles of microRNA-target recognition. PLoS Biol 3: e85, 2005.
17. Mulrane L, McGee SF, Gallagher WM and O'Connor DP: miRNA dysregulation in breast cancer. Cancer Res 73: 6554-6562, 2013.
18. Capodanno A, Boldrini L, Proietti A, et al: Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features. Int J Oncol 43: 765-774, 2013.
19. Adinolfi E, Raffaghello L, Giuliani AL, et al: Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72: 2957-2969, 2012.
20. White N and Burnstock G: P2 receptors and cancer. Trends Pharmacol Sci 27: 211-217, 2006.
21. Adinolfi E, Melchiorri L, Falzoni S, et al: P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99: 706-708, 2002.
22. Chong JH, Zheng GG, Zhu XF, et al: Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias. Biochem Biophys Res Commun 391: 498-504, 2010.
23. Raffaghello L, Chiozzi P, Falzoni S, Di Virgilio F and Pistoia V: The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res 66: 907-914, 2006.
24. Solini A, Cuccato S, Ferrari D, et al: Increased P2X7 receptor expression and function in thyroid papillary cancer: a new potential marker of the disease? Endocrinology 149: 389-396, 2008.
25. Slater M, Danieletto S, Pooley M, Cheng TL, Gidley-Baird A and Barden JA: Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res Treat 83: 1-10, 2004.
26. Souza CO, Santoro GF, Figliuolo VR, et al: Extracellular ATP induces cell death in human intestinal epithelial cells. Biochim Biophys Acta 1820: 1867-1878, 2012.
27. Bian S, Sun X, Bai A, et al: P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS One 8: e60184, 2013.